Towards a New Treatment Era?: Translating Results from START and TEMPRANO to Clinical Practice
Serge Eholié, Ivory Coast
Serge Paul Eholié is a professor of Infectious and Tropical Diseases at Treichville University Teaching Hospital in Abidjan, Côte d’Ivoire. He is also a senior lecturer at the University Felix Houphouet Boigny Medical School in Abidjan, Côte d’Ivoire. Dr. Eholié received his medical degree from the university of Abidjan and later specialized in infectious and tropical diseases. He was trained in HIV management in France (Marseille and Paris) and has served as a trainer In HIV in several African countries. He is currently the deputy director of the National Agency for Research on AIDS and Hepatitis (ANRS) Research Centre of Abidjan, the President of the Réseau Africain des Praticiens Assurant la prise en charge des personnes vivant avec le VIH/SIDA (RESAPSI), and is the vice president of Alliance Francophone des Acteurs de la Santé contre le VIH (AFRAVIH). He co-chaired the WHO clinical guidelines developing group for the 2013 and 2015 guidelines. He is currently involved in research around HIV therapeutic strategies, HIV and hepatitis co-morbidities, HIV and non-communicable diseases, HIV and ageing, and Ebola therapeutic and vaccine trials.
A Lifetime of Support: How We Ended Paediatric AIDS
Dorothy Mbori-Ngacha, UNICEF
Dr Dorothy Mbori-Ngacha is a medical epidemiologist with specialist training in paediatrics, infectious diseases and child health. She is currently Chief of the HIV Section at UNICEF Nigeria. Prior to this, she was the Senior HIV Specialist at UNICEF in the Eastern and Southern Africa Region, where her main focus was on Prevention of Mother to Child Transmission (PMTCT) and paediatric HIV. Other positions she has had held include Chair and Associate Professor in the Department of Paediatrics at the University of Nairobi, Affiliate Associate Professor in the Department of Epidemiology at the University of Washington and Deputy Director for Programmes for the US Centers for Disease Control and Prevention (CDC) Global AIDS Programme in Kenya. For her work in paediatric AIDS, Dr Mbori-Ngacha received the Elizabeth Glaser Pediatrics AIDS Foundation International Leadership Award in 2002.
Essential Medicines, IP and Access
Malebona Precious Matsoso, South Africa
Malebona Precious Matsoso was appointed Director General of the National Department of Health in South Africa in June 2010. Previously the Director of the Public Health, Innovation and Intellectual Property Programme at the World Health Organization, Matsoso was responsible for the implementation of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Matsoso has been a member of various advisory panels locally and internationally, with a primary focus on improving access to medicines. Prior to her international assignments, she was the Registrar of Medicines for the Medicines Control Council in South Africa and held several senior positions in the South African Government.
What’s New, What’s Next, What’s Ahead?
Carlos del Rio, Mexico
Since his days as a physician in training, Dr del Rio has worked to reduce the spread of HIV on multiple fronts—leading the National AIDS Program in his native Mexico, caring for patients at Grady Memorial Hospital, directing the NIH-sponsored HIV Prevention Trials Network at Emory University Rollins School of Public Health (Emory RSPH), advising US agencies on HIV prevention and care, and growing global capacity for HIV research. Dr del Rio, Hubert Professor and Chair of the Hubert Department of Global Health at Emory RSPH, also co-directs the Emory Center for AIDS Research and leads the Emory AIDS International Training and Research Programme.
– By
